Brian Baloun is an associate in the Chicago office of Latham & Watkins. Mr. Baloun advises global clients, including public and privately held companies, as well as private equity sponsors, family offices, and their portfolio companies, on complex global and domestic M&A transactions.

Mr. Baloun’s representative experience includes advising:

Public Company M&A

  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company developing new medicines for the treatment of bone marrow diseases, in its pending US$1.35 billion take-private sale to Merck & Co., Inc.
  • Flame Acquisition Corp., a special purpose acquisition entity focused on the energy industry in North America, in its business combination with Sable Offshore Corp.
  • ironSource Ltd., a leading business platform that empowers mobile content creators to turn their apps into scalable businesses, in its US$4.4 billion merger with Unity Software, Inc.
  • Cerner Corporation, a leading provider of digital information services used within hospitals and health systems, in its US$28 billion take-private sale to Oracle
  • Silicon Motion Technology Corporation, a global leader in designing and marketing NAND flash controllers for solid state storage devices, in its pending US$3.8 billion take-private sale to MaxLinear, Inc.

Private Company M&A

  • Crown Paper Group, an integrated mill and containerboard operation with a strategic presence in the growing markets of the Pacific Northwest and Western Canada, in its sale to Atlas Holdings.

Private Equity / Family Office M&A

  • BDT Capital in several acquisitions, joint ventures, and strategic partnerships
  • A private equity sponsor in connection with an acquisition in the utility industry
  • GTCR in its acquisition of Katena Products, Inc., a medical device company focused on ophthalmic surgery products

Bar Qualification

  • Illinois

Education

  • JD, Loyola University Chicago School of Law, 2020
    Magna Cum Laude
  • B.A. in Political Science, University of Iowa, 2016